CompletedNCT01433055
Minocycline or Placebo Added to Clozapine for Schizophrenia
About this title
Read the official source —Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- CatonsvilleSee all locations and recruitment
Study information
Study start dateJuly 2011
- Recruitment status
- Completed
- Enrollment listed in the registry
- 52
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01433055
- Official title
Show the full official title
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients
Get this study by email
Recruitment & locations
CompletedCatonsville
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Did this study involve medication?
Yes. The study involved medication, including Minocycline and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to explore more studies?
Explore studiesRelated studies
Paliperidone Injections Compared With Oral Medication for Schizophrenia
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia